- Report
- April 2026
- 160 Pages
Global
From €3779EUR$4,150USD£3,256GBP
- Report
- February 2026
- 250 Pages
Global
From €4088EUR$4,490USD£3,522GBP
- Report
- May 2026
- 100 Pages
Global
From €3638EUR$3,995USD£3,134GBP
- Report
- June 2026
- 470 Pages
Global
From €6369EUR$6,995USD£5,487GBP
- Report
- July 2025
- 150 Pages
Global
From €5418EUR$5,950USD£4,668GBP
- Report
- January 2026
- 186 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- June 2026
- 191 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- June 2026
- 180 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- June 2026
- 189 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- June 2026
- 182 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- June 2026
- 182 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- June 2026
- 194 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- January 2026
- 181 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- January 2026
- 184 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- January 2026
- 190 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- January 2026
- 191 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- January 2026
- 188 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- January 2026
- 199 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- January 2026
- 188 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP
- Report
- January 2026
- 191 Pages
Global
From €3228EUR$3,545USD£2,781GBP
€3587EUR$3,939USD£3,090GBP

The Macrolide Antibiotic market is a segment of the Infectious Diseases Drugs market. Macrolides are a class of antibiotics used to treat a wide range of bacterial infections, including respiratory tract infections, skin infections, and sexually transmitted diseases. Macrolides are generally well-tolerated and have fewer side effects than other antibiotics. They are also effective against drug-resistant bacteria, making them an important tool in the fight against antibiotic resistance. Macrolides are available in both oral and intravenous formulations, and are often used in combination with other antibiotics.
The Macrolide Antibiotic market is highly competitive, with a number of large pharmaceutical companies offering products. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, and Novartis. Show Less Read more